Peter Vickerman
Overview
Explore the profile of Peter Vickerman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
347
Citations
9528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Artenie A, Trickey A, Looker K, Stone J, Lim A, Fraser H, et al.
Lancet Gastroenterol Hepatol
. 2025 Feb;
10(4):315-331.
PMID: 39993400
Background: Measuring progress towards the WHO 2030 target for hepatitis C virus (HCV) elimination among people who inject drugs (PWID)-an incidence of two or fewer infections per 100 person-years-has been...
2.
DOttavi M, Godfrey-Faussett P, Merle C, Sofonea M, Laureillard D, Vickerman P, et al.
Lancet Glob Health
. 2025 Jan;
13(3):e593-e598.
PMID: 39862874
People who use drugs show a higher incidence and prevalence of tuberculosis than people who do not use drugs in areas where Mycobacterium tuberculosis is endemic. However, this population is...
3.
Zhang Y, Ho T, Terris-Prestholt F, Quaife M, De Bekker-Grob E, Vickerman P, et al.
EClinicalMedicine
. 2025 Jan;
79():102965.
PMID: 39791109
Background: Discrete choice experiments (DCEs) are increasingly used to inform the design of health products and services. It is essential to understand the extent to which DCEs provide reliable predictions...
4.
Ward Z, Simmons R, Fraser H, Trickey A, Kesten J, Gibson A, et al.
Lancet Reg Health Eur
. 2025 Jan;
49:101176.
PMID: 39759576
Background: England aims to reach the World Health Organization (WHO) elimination target of decreasing HCV incidence among people who inject drugs (PWID) to <2 per 100 person-years (/100pyrs) by 2030....
5.
Grenfell P, Elmes J, Stuart R, Eastham J, Walker J, Browne C, et al.
Public Health Res (Southampt)
. 2024 Dec;
:1-53.
PMID: 39711037
Background: Sex workers' risk of violence and ill-health is shaped by their work environments, community and structural factors, including criminalisation. Aim: We evaluated the impact of removing police enforcement on...
6.
Zhang X, Luo H, Charlett A, DeAngelis D, Liu W, Vickerman P, et al.
BMC Glob Public Health
. 2024 Dec;
2(1):38.
PMID: 39681927
Background: Understanding how the COVID-19 pandemic evolved under control measures is crucial to tackle the SARS-CoV-2 virus spread. Laos, a country bordering China but with late occurrence and low burden...
7.
Jemutai J, Downs L, Anderson M, Cohen C, Seeley J, Sultan B, et al.
Lancet Gastroenterol Hepatol
. 2024 Dec;
10(2):100-103.
PMID: 39681128
No abstract available.
8.
Artenie A, Perry R, Mahaso M, Jankie T, McNaughton A, Stone J, et al.
Lancet HIV
. 2024 Dec;
11(12):e823-e832.
PMID: 39632050
Background: HIV incidence among people who inject drugs in South Africa has never been estimated. We aimed to estimate HIV incidence and associations with risk and protective factors among people...
9.
Kassa G, Weldemariam A, Abrahim S, French C, Wolday D, Dagne E, et al.
J Viral Hepat
. 2024 Nov;
32(4):e14037.
PMID: 39569765
Hepatitis C virus (HCV) is hypothesised to be a public health problem in Ethiopia, and systematic review evidence suggested 1%-3% seroprevalence. We aimed to estimate the seroprevalence of HCV overall...
10.
Stannah J, Anato J, Pickles M, Larmarange J, Mitchell K, Artenie A, et al.
BMC Med
. 2024 Sep;
22(1):404.
PMID: 39300441
Background: Including structural determinants (e.g. criminalisation, stigma, inequitable gender norms) in dynamic HIV transmission models is important to help quantify their population-level impacts and guide implementation of effective interventions that...